Coronary heart disease secondary prevention blood pressure control
|
Coronary heart disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Coronary heart disease secondary prevention blood pressure control On the Web |
|
American Roentgen Ray Society Images of Coronary heart disease secondary prevention blood pressure control |
|
FDA on Coronary heart disease secondary prevention blood pressure control |
|
CDC on Coronary heart disease secondary prevention blood pressure control |
|
Coronary heart disease secondary prevention blood pressure control in the news |
|
Blogs on Coronary heart disease secondary prevention blood pressure control |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Goal: <140/90 mm Hg or <130/80 mm Hg if patient has diabetes or chronic kidney disease.
Blood Pressure Control
- If blood pressure is > 120/80 mm Hg:
Initiate or maintain lifestyle modification (weight control, EtOH moderation, sodium reduction, increased physical activity, increased fruits, vegetables, low-fat dairy)
- If blood pressure > 140/90 mm Hg: As tolerated, add blood pressure medication (betablockers and/or ACE inhibitors initially).
AHA / ACC 2006 Guidelines - Coronary Heart Disease - Secondary Prevention with Blood Pressure Management (DO NOT EDIT)[1]
| Class I |
| "1. All patients should be counseled regarding the need for lifestyle modification: weight control; increased physical activity; alcohol moderation; sodium reduction; and emphasis on increased consumption of fresh fruits, vegetables, and low-fat dairy products. (Level of Evidence: B) " |
| "2. Patients with blood pressure ≥140/90 mm Hg should be treated, as tolerated, with blood pressure medication, treating initially with β-blockers and/or ACE inhibitors, with addition of other drugs as needed to achieve goal blood pressure.(Level of Evidence: A)" |
References
- ↑ AHA. ACC. National Heart, Lung, and Blood Institute. Smith SC, Allen J, Blair SN; et al. (2006). "AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute". J Am Coll Cardiol. 47 (10): 2130–9. doi:10.1016/j.jacc.2006.04.026. PMID 16697342.